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Accepted 3 November 2011AbstractObjective: Benign or mature cystic teratomas, also known as dermoid cysts, are composed of mature tissues, which can contain elements of all three
germ cell layers. Malignant transformation of a mature cystic teratoma is more common in postmenopausal women, however, it can also, rarely, be
identified in younger women. We present a case of a 19-year-old woman with malignant transformation of an ovarian mature cystic teratoma.
Case Report: Our case was a 19-year-old woman, who was diagnosed postoperatively with follicular variant of papillary thyroid carcinoma in
a mature cystic teratoma. She underwent right cystectomy for adnexal mass. Postoperative metastatic workup revealed a non-metastatic disease
and the patient did not undergo any further treatment. After 2 months, a near-total thyroidectomy was performed. Serum thyroglobulin levels
were monitored on follow-up and the patient is asymptomatic.
Conclusion: Malignant transformation of a dermoid cyst is a rare ovarian neoplasm. We believe that unilateral oophorectomy or cystectomy is
a reasonable treatment option for cases in which there is no evidence of capsular invasion, vascular invasion or gross metastasis, and preservation
of fertility is desired. Total thyroidectomy was diagnosed in selected cases. Serial serum thyroglobulin should be used as a tumor marker for
follow-up.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The term teratoma is derived from the Greek root “teratos”
which means monster [1]. Mature cystic teratoma (MCT),
commonly referred to as a dermoid cyst of the ovary, is the most
common type of ovarian teratoma and germ cell neoplasm
comprising 10e20% of ovarian tumors [2]. In its pure form,
MCT is always benign, however, malignant transformation of
MCT has been reported, rarely, with a rate ¼ 1e2% [3].
Malignant transformation is most common in postmenopausal
women, however, it can also be rarely identified in younger
women. The most common malignant tumor in mature cystic* Corresponding author. Haseki Training and Research Hospital, Department
of Gynecology and Obstetrics, Istanbul, Turkey.
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http://dx.doi.org/10.1016/j.tjog.2012.07.019teratomas is squamous cell carcinoma, whereas, papillary
thyroid carcinoma caused by mature cystic teratomas is
extremely rare. Malignant transformation is rarely diagnosed
pre-operatively, due to its rarity [4]. Hence, in most cases,
malignant transformation is most commonly diagnosed only by
post-operative pathological examination.
In this paper, we report a rare case of follicular variant
papillary thyroid cancer arising from a mature cystic teratoma
of the ovary, which was unexpectedly discovered during
histopathologic examination.Case report
A 19-year-old woman was admitted to our gynecology
policlinic with a complaint of 3 months duration of amenorrheacs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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examination and had no history of pregnancy. Her physical
examination revealed a mass in the abdominal region. Trans-
vaginal ultrasonography revealed a mass ¼ 15 cm  16 cm,
containing hyperechogenic areas. FromMRIfindings, the tumor
was considered to be an ovarian cystic tumor containing a fatty
structure (Fig. 1). A laparotomy was performed and the findings
were as follows: the right dermoid ovarian cyst was hairy and
had a solid component, size¼ 14 cm 15 cm; the size and shape
of the uterus, the left ovary and the tubes were normal. No other
pelvic pathology was observed and liver and mesenteric
examinations were normal. The mass appeared to have origi-
nated from the right ovary,wasmobile and had a smooth surface.
An ovarian cystectomy was performed. Macroscopic appear-
ance of the lesion resembled a dermoid cyst involving adipose
like tissue, hair and tooth. No palpable lymph nodes were seen.
Histopathologic evaluation of the lesion demonstrated a follic-
ular variant papillary thyroid carcinoma in a mature cystic
teratoma as the microscopic focus, surrounded by normal
ovarian tissue. Microscopic examination showed the thyroid
tissue in the mature cystic teratoma to be 2.5 cm. Thyroid tissue
composed of follicles, lined with cuboidal epithelium and filled
with colloid was seen at one focus containing a 0.2 cm sized
encapsulated follicular variant of thyroid papillary carcinoma.
Immunochemistry demonstrated focal membrane staining with
HBME-1 (Fig. 2). The tumor was limited to the thyroid gland
and did not impact the ovarian capsule or vascular spaces. TheFig. 1. MR images show the mass with high-signal-intensity due to its
mucinous contents. Low-signal-intensity central nodule is also seen.
Fig. 2. (A) follicular variant papillary thyroid carcinoma within an ovarian
teratoma. Normal ovarian tissue is seen on the right. On the right, normal-
appearing thyroid tissue merges with a focus of follicular variant papillary
thyroid carcinoma (H&E,  40); (B) membrane positivity for HBME-1
(H&E  400); and (C) follicular variant of papillary thyroid carcinoma,
exhibiting clear nuclei, prominent nucleoli, occasional nuclear grooves, and
follicles with scalloping (H&E  400).
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follicular variant papillary thyroid carcinoma arising in amature
cystic teratoma. There was no immature tissue inside the tera-
toma. Peritoneal washing showed benign mesothelial cells.
Thyroid ultrasonography was necessary to eliminate any
primary thyroid malignancy. Multiple nodes were detected at
both the right and left lobes of the gland. Fine needle aspiration
biopsy revealed benign thyroid nodules. The serum thyroglob-
ulin level ¼ 73.4 ng/mL (normal range 0.73e 84 ng/mL).
Thyroid-stimulating hormone ¼ 0.62 mIU/mL (normal
range¼ 0.35e5mIU/mL), free thyroxine¼ 1.37 ng/dL (normal
range¼ 0.7e1.9 ng/dL) and free triiodothyronine¼ 3.18 pg/mL
(normal range ¼ 1.57e4.71 pg/mL) (1 month after surgery).
After 2 months, a near- total thyroidectomy was performed and
pathological examination of the thyroid gland was normal. The
patient was started on exogenous thyroid hormone. Serum
thyroglobulin levelsweremonitored on follow-up of the patient.
Five months after surgery and taking levothyroxine,
thyroglobulin ¼ 3.65 ng/dL, TSH ¼ 0.64 mIU/L and
FT4 ¼ 1.31 ng/dL. The patient was under surveillance for 6
months, with no evidence of recurrence.
Discussion
A mature cystic teratoma of the ovary or dermoid cyst is
composed of well-differentiated derivatives of the three germTable 1
Clinical details of the patients with papillary thyroid carcinoma on thyroid tissue
Patient Study Age (y) Symptoms at diagnosis Tumor
1 Chadha [12] 71 Abdominal pain 18
2 Doldi [13] 58 Abdominal swelling and
discomfort
4
3 Krnojelac [14] 43 During c/s 8
4 Zergeroglu [15] 28 Abdominal discomfort, pain 9  8
5 Sayhan [16] 71 Abdominal pain 12 
6 Soto-Moreno [17] 31 Episode of metrorrhagia 7  5
7 Bal [1] 60 Post-menopausal bleeding 7
8 Ryder [18] 49 Abdominal pain and emesis 4.6
9 Lee [19] 35 Intermittent low abdominal
discomfort
13 
10 Quadri [20] 54 Lower abdominal pain 8  7
11 Al-Nawafleh [21] 36 Left lower abdominal pain 6  5
12 Lataifeh [22] 39 Incidental 4.5
13 Bougerra [23] 44 Abdomino pelvic mass- painless 20 
14 Tanaka [24] 50 Hypermenorrhea 8
15 Our case 19 Abdominal distension 15 
LSO ¼ laparoscopical salpingo-oophorectomy; TAH ¼ total abdominal hysterec
oophorectomy.layers, the ectoderm, the mesoderm and the endoderm, while
ectodermal elements usually predominate. Complications of
cystic teratomas include torsion (16%), malignant degenera-
tion (2%), rupture (1e2%), and infection (1%) [5]. Malignant
transformation is usually diagnosed postoperatively, from the
histological findings. In 1957, Peterson reviewed 229 cases of
malignant transformation of mature cystic teratomas [6]. He
reported malignant transformation rates of 1.8%; 81.1% of the
tumors were squamous cell carcinomas and 6% were adeno-
carcinomas. The other malignant transformations include
malignant melanoma, sarcoma, basal cell carcinoma, carcinoid
tumor, adenocarcinoma of intestinal epithelium, and thyroid
carcinoma [7,8].
Malignant transformation of thyroid tissue in MCT can be
classified histopathologically into three types [9]. The first and
most common type is papillary carcinoma (44%). The
malignant features of these tumors include optically clear or
ground-glass overlapping nuclei with nuclear grooves. The
second type is follicular carcinoma, which is diagnosed when
cells containing mitotic figures begin forming follicles and
capsular or vascular invasion is noted. Follicular carcinoma
accounts for approximately 30% of malignant degeneration in
MCT. Lastly, there is a follicular variant of a papillary carci-
noma, which accounts for 26% of malignant degeneration.
This follicular variant is unique because it shares similar
nuclear cytological features of a papillary carcinoma; it has,in an ovarian teratoma (excluded struma ovarii cases).
size (cm) Intervention Pathology Thyroidectomy
TAH þ BSO Follicular thyroid
carcinoma
Not reported
Tumor resection Papillary carcinoma
of the thyroid
Not reported
Oophorocystectomy Papillary carcinoma
of the thyroid
Yes
TAH þ BSO Papillary carcinoma
of the thyroid
Not reported
10  8 TAH þ BSO Papillary carcinoma
of the thyroid
Unknown
Tumor resection Papillary carcinoma Yes
TAH þ BSO Papillary carcinoma Unknown
Unilateral
oophorocystectomy
Follicular variant
papillary
thyroid carcinoma
Unknown
11 LSO followed
by TAH þ USO
Papillary carcinoma,
follicular variant
Unknown
 4 TAH þ BSO papillary carcinoma,
follicular variant
Yes
LSO Papillary carcinoma Unknown
LSO Papillary thyroid cancer Yes
13 TAH þ BSO Papillary thyroid
carcinoma
Yes
TAH þ BSO Follicular variant
thyroid-type
papillary carcinoma
Unknown
16 Cystectomy Follicular variant
papillary
thyroid carcinoma
Yes
tomy; BSO ¼ bilateral salpingo-oophorectomy; USO ¼ unilateral salpingo-
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variant papillary thyroid carcinoma was found. It is a teratoma
with no predominance of thyroid tissue, where we found
a limited area with typical histological characteristics of
a follicular variant papillary thyroid carcinoma and positive
thyroglobulin on immunohistochemical analysis. Thus, it is
considered a papillary carcinoma on thyroid tissue in an
ovarian teratoma.
The presence of thyroid tissue in the ovaries was first
described by Von Kahlden in 1895 [10]. Papillary thyroid
cancer arising from ovarian teratomas is a rare occurrence,
with an estimate of 0.1e0.3% [11]. To date, only 15 cases of
papillary thyroid carcinoma arising in a mature cystic teratoma
of the ovary have been reported. Herein, we report the clini-
copathologic features of one such case. A review of the
literature is also presented (Table 1) [1,12e24]. The average
age was 45 years. These patients predominantly presented
with abdominal pain (50%), a pelvic mass (12%) and
menstrual irregularities (12%). Papillary carcinoma was the
most common (60%) histopathological finding followed by
follicular variant of papillary carcinoma (33%) and follicular
carcinoma (6%).
The survival outcome of patients with malignant trans-
formation of the ovarian mature cystic teratomas is dependent
on the stage. These tumors arising from ovarian teratomas can
occasionally present with locally invasive disease, or with
distant metastases, and may be associated with recurrences in
some patients. In the present case, a cystic lesion was found on
the right ovary, but no suspicious clinical features such as
rupture, tumor dissemination, ascites or adhesions were
observed. The optimal treatment for malignant transformation
of MCT is uncertain because of the rarity of the disease [21].
This rarity suggests a low likelihood of future prospective
studies to determine the best treatment options. Conservative
treatment is often offered to younger patients who wished to
retain their fertility and it consists of unilateral salpingo-
oophorectomy or cystectomy without adjuvant therapy.
Conservation of ovarian tissue on the affected side is accept-
able. In the 19-year-old patient, cystectomy was performed in
order to preserve fertility. The patient was treated by cys-
tectomy with the intact removal of the cyst without spillage.
Subsequently, thyroidectomy was performed to rule out
primary thyroid papillary carcinoma, because the thyroid
ultrasound scan showed multinodular goiter, and the patient
was started on exogenous thyroid hormone. These patients
must undergo a thyroidectomy, which serves two purposes
[25]: (1) it ensures that the patient’s thyroid is normal and
rules out the possibility of metastasis to the ovaries; and (2) it
potentiates iodine therapy, because the removal of all normal
thyroid tissue allows the radioactive iodine to concentrate in
the accessory thyroid tissue. Thyroglobulin, produced by both
normal and abnormal thyroid tissue, has been used as a post-
operative tumor marker. Serum thyroglobulin levels are
checked every 4 months during the 1st year after surgery. If
a patient’s thyroglobulin level is unexpectedly high, a radio-
active iodine scan is carried out, in order to evaluate for
recurrence.After thyroidectomy, we followed up the patient by
measuring serum thyroglobulin levels, with periodic trans-
vaginal ultrasonography and abdominal MRI. During a 6
month long follow up, we did not find any evidence of
recurrence or metastasis.
In conclusion, we describe follicular variant papillary
thyroid carcinoma arising from the thyroidal tissue of an
ovarian dermoid cyst.References
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